Nice!
I'll take 86% - feels about right to me
"By the end of the year,Paradigm Biopharmaceuticals (ASX: PAR)is due to report on a Phase 2/3 trial for its repurposed drug to treat knee osteoarthritis.
The algo ascribes a high success probability of just under 86 per cent, partly because of the high enrolment of 900 patients.
"
research reports and media, page-4116
-
- There are more pages in this discussion • 313 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |